Hepatitis B virus nucleocapsid but not free core antigen controls viral clearance in mice

Journal of Virology

Volumn 86, Issue 17, 2012, Pages 9266-9273

  Lin, Yi Jiun ^a   Wu, Hui Lin ^a   Chen, Ding Shinn ^a   Chen, Pei Jer ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; VIRUS MESSENGER RNA;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENETIC COMPLEMENTATION; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRAL CLEARANCE; VIRUS ASSEMBLY; VIRUS CHARACTERIZATION; VIRUS MUTANT; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HEPATITIS B VIRUS; MIRIDAE; MUS;

EID: 84984549251     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00608-12     Document Type: Article

References (38)

1. Bartenschlager R, Junker-Niepmann M, Schaller H. 1990. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64:5324-5332.
2. Bertoletti A, Maini MK, Ferrari C. 2010. The host-pathogen interaction during HBV infection: immunological controversies. Antivir. Ther.15(Suppl 3):15-24.
3. Billaud JN, et al. 2005. Combinatorial approach to hepadnavirus-like particle vaccine design. J. Virol. 79:13656-13666.
4. Birnbaum F, Nassal M. 1990. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J. Virol. 64:3319-3330.
5. Bourne CR, Katen SP, Fulz MR, Packianathan C, Zlotnick A. 2009. A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly. Biochemistry 48:1736-1742.
6. Chintakuntlawar AV, Zhou X, Rajaiya J, Chodosh J. 2010. Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog. 6:e1000841. doi:10.1371/journal.ppat.1000841.
7. Dunn C, et al. 2009. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137:1289-1300.
8. Eckhardt SG, Milich DR, McLachlan A. 1991. Hepatitis B virus core antigen has two nuclear localization sequences in the arginine-rich carboxyl terminus. J. Virol. 65:575-582.
9. Fisicaro P, et al. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58:974-982.
10. Guidotti LG, et al. 2002. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 76:2617-2621.
11. Guy CS, Mulrooney-Cousins PM, Churchill ND, Michalak TI. 2008. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 82:8579-8591.
12. He XX, et al. 2010. Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol. 23:251-257.
13. Hirsch RC, Lavine JE, Chang LJ, Varmus HE, Ganem D. 1990. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344:552-555.
14. Hosel M, et al. 2009. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 50:1773-1782.
15. Huang LR, Wu HL, Chen PJ, Chen DS. 2006. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 103:17862-17867.
16. Kumar M, et al. 2011. Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J. Virol. 85:987-995.
17. Le Pogam S, Chua PK, Newman M, Shih C. 2005. Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173). J. Virol. 79:1871-1887.
18. Lin YJ, et al. 2010. Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model. Proc. Natl. Acad. Sci. U. S. A. 107:9340-9345.
19. Lucifora J, et al. 2010. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology 51:63-72.
20. Manel N, et al. 2010. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467:214-217.
21. Milich DR, McLachlan A, Thornton GB, Hughes JL. 1987. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329:547-549.
22. Pertel T, et al. 2011. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472:361-365.
23. Porterfield JZ, et al. 2010. Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J. Virol. 84:7174-7184.
24. Riedl P, et al. 2002. Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain. J. Immunol. 168:4951-4959.
25. Sebastian S, Luban J. 2005. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2:40. doi:10.1186/1742-4690-2-40.
26. Seeger C, Mason WS. 2000. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64:51-68.
27. Stacey AR, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83:3719-3733.
28. Stremlau M, et al. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U. S. A. 103:5514-5519.
29. Wang H, Ryu WS. 2010. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 6:e1000986. doi:10.1371/journal.ppat.1000986.
30. Wei C, et al. 2010. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 185:1158-1168.
31. Wieland S, Thimme R, Purcell RH, Chisari FV. 2004. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. U. S. A. 101:6669-6674.
32. Wu HL, et al. 2005. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology 128:708-716.
33. Wu J, et al. 2010. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 129:363-374.
34. Wynne SA, Crowther RA, Leslie AG. 1999. The crystal structure of the human hepatitis B virus capsid. Mol. Cell 3:771-780.
35. Yang PL, et al. 2010. Immune effectors required for hepatitis B virus clearance. Proc. Natl. Acad. Sci. U. S. A. 107:798-802.
36. Yu S, et al. 2010. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J. Gen. Virol. 91:2080-2090.
37. Zhou J, et al. 2007. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J. Hepatol. 46:198-205.
38. Zhou J, et al. 2009. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J. Viral Hepat. 16:45-52.